Menopausal status: An important consideration in determining the biology and prognosis of estrogen receptor-positive and progesterone receptor-negative breast cancer

被引：0
|
作者：
Fujisue, M.
Nishimura, R.
Nakano, M.
Tashima, R.
Nishiyama, Y.
Osako, T.
Toyozumi, Y.
Arima, N.
机构：
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P5-05-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-05-06
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer
    Yu Fan
    Xiaorong Zhong
    Yu Wang
    Zhu Wang
    Ting Luo
    Yanping Wang
    Hong Zheng
    Breast Cancer Research and Treatment, 2023, 200 : 171 - 182
  • [42] Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI?
    Chen, J. -H.
    Hsu, F. -T.
    Shih, H. -N.
    Hsu, C. -C.
    Chang, D.
    Nie, K.
    Nalcioglu, O.
    Su, M. -Y.
    ANNALS OF ONCOLOGY, 2009, 20 (08) : 1447 - 1449
  • [43] Tumor biology in estrogen receptor-positive, human epidermal growth factor receptor type 2-negative breast cancer: Mind the menopausal status
    Yamashita, Hiroko
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2015, 6 (06): : 220 - 224
  • [44] Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor-positive/progesterone receptor-negative breast cancer
    Fohlin, Helena
    Bekkhus, Tove
    Sandstrom, Josefine
    Fornander, Tommy
    Nordenskjold, Bo
    Carstensen, John
    Stal, Olle
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 12 (05) : 415 - 420
  • [45] BIOCHEMICALLY ESTROGEN RECEPTOR-NEGATIVE, PROGESTERONE RECEPTOR-POSITIVE BREAST-CARCINOMA - IMMUNOCYTOCHEMICAL HORMONE RECEPTORS AND PROGNOSTIC FACTORS
    KESHGEGIAN, AA
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1994, 118 (03) : 240 - 244
  • [46] Estrogen receptor β- an independent prognostic marker in estrogen receptor α and progesterone receptor-positive breast cancer?
    Maehle, Bjorn O.
    Collett, Karin
    Tretli, Steinar
    Akslen, Lars A.
    Grotmol, Tom
    APMIS, 2009, 117 (09) : 644 - 650
  • [47] Clinical considerations for estrogen receptor-negative/ progesterone receptor-positive/HER2-negative (ER-PR+HER2-) breast cancer
    Rala de Paula, Bruno Henrique
    Crocamo, Susanne
    Bines, Jose
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
  • [48] Genes Dysregulated to Different Extent or Oppositely in Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers
    Zhou, Xianxiao
    Shi, Tongwei
    Li, Bailiang
    Zhang, Yuannv
    Shen, Xiaopei
    Li, Hongdong
    Hong, Guini
    Liu, Chunyang
    Guo, Zheng
    PLOS ONE, 2013, 8 (07):
  • [49] Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer
    Hoon, Siao-Nge
    Lau, Peter K. H.
    White, Alison M.
    Bulsara, Max K.
    Banks, Patricia D.
    Redfern, Andrew D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (05):
  • [50] Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy
    He Dou
    Fucheng Li
    Youyu Wang
    Xingyan Chen
    Pingyang Yu
    Siyuan Jia
    Yuling Ba
    Danli Luo
    Tian Gao
    Zhaoting Li
    Min Xiao
    Diagnostic Pathology, 19
12345